ESR1 and prostate carcinoma: Although DDT mimics the actions of estrogen by binding to estrogen receptors, and p,p′-DDE has been demonstrated to be antiandrogenic (Kelce et al. 1995), plasma DDT and DDE levels in our study were not associated with prostate cancer.